Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.53B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.28B |
| 3 |
Microsoft
MSFT
|
+$1.27B |
| 4 |
Intercontinental Exchange
ICE
|
+$876M |
| 5 |
Parker-Hannifin
PH
|
+$753M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Visa
V
|
+$890M |
| 3 |
Fortive
FTV
|
+$739M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$457M |
| 5 |
TSMC
TSM
|
+$392M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.21% |
| 2 | Technology | 17.8% |
| 3 | Industrials | 7.2% |
| 4 | Consumer Discretionary | 7% |
| 5 | Healthcare | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.9B
| $170M | 0.03% |
3,013,607
+561,095
| +23% | +$31.5M |
|
402
Realty Income
O
$59.8B
| $170M | 0.03% |
3,174,507
+193,013
| +6% | +$11.2M |
|
403
iShares Core S&P Total US Stock Market ETF
ITOT
$98.4B
| $169M | 0.03% |
1,317,577
-9,887
| -0.7% | -$1.28M |
|
404
First Trust Value Line Dividend Fund
FVD
$8.38B
| $169M | 0.03% |
3,882,042
-116,490
| -3% | -$5.27M |
|
405
Edwards Lifesciences
EW
$53.5B
| $169M | 0.03% |
2,287,681
+315,968
| +16% | +$22.1M |
|
406
Prudential Financial
PRU
$42.9B
| $168M | 0.03% |
1,420,697
+357,230
| +34% | +$44.1M |
|
407
iShares Russell 1000 ETF
IWB
$50.4B
| $166M | 0.03% |
515,676
-68,008
| -12% | -$22M |
|
408
Unilever
UL
$135B
| $166M | 0.03% |
2,601,682
+12,518
| +0.5% | +$845K |
|
409
Microchip Technology
MCHP
$43.3B
| $166M | 0.03% |
2,888,806
-857,759
| -23% | -$59M |
|
410
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.6B
| $164M | 0.03% |
1,861,628
+68,942
| +4% | +$5.96M |
|
411
NetApp
NTAP
$40B
| $164M | 0.03% |
1,408,716
-26,282
| -2% | -$3.21M |
|
412
Alibaba
BABA
$292B
| $163M | 0.03% |
1,926,904
-221,248
| -10% | -$20.9M |
|
413
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $163M | 0.03% |
4,518,829
+276,173
| +7% | +$10.1M |
|
414
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
| $162M | 0.03% |
3,218,770
+164,141
| +5% | +$8.26M |
|
415
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.4B
| $162M | 0.03% |
3,211,056
-908,694
| -22% | -$45.9M |
|
416
ATS Corp
ATS
$1.98B
| $162M | 0.03% |
5,307,964
+1,452,667
| +38% | +$44.1M |
|
417
iShares MBS ETF
MBB
$39.2B
| $161M | 0.03% |
1,759,512
-59,356
| -3% | -$5.53M |
|
418
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $161M | 0.03% |
1,508,436
+417,386
| +38% | +$45.7M |
|
|
419
CALL
NVIDIA
NVDA
$5.46T
| $161M | 0.03% |
1,198,900
-444,000
| -27% | -$61.2M |
|
420
iShares Biotechnology ETF
IBB
$9.8B
| $159M | 0.03% |
1,206,172
-266,253
| -18% | -$37.4M |
|
421
AstraZeneca
AZN
$245B
| $159M | 0.03% |
1,216,406
-29,190
| -2% | -$4.09M |
|
422
iShares Gold Trust
IAU
$64.6B
| $159M | 0.03% |
3,214,391
-373,729
| -10% | -$18.8M |
|
423
TotalEnergies
TTE
$193B
| $159M | 0.03% |
2,917,438
+265,251
| +10% | +$16.1M |
|
424
Ryanair
RYAAY
$30.8B
| $159M | 0.03% |
3,642,795
+179,006
| +5% | +$7.99M |
|
425
Dr. Reddy's Laboratories
RDY
$10.3B
| $158M | 0.03% |
10,037,246
+61,831
| +0.6% | +$929K |
|
Similar funds
Royal Bank of Canada's Q4 2024 Portfolio in Review
As of Q4 2024, Royal Bank of Canada held 7,459 positions worth $501B, up 2.2% from $490B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q4 2024 filing shows 484 new, 3,145 increased, 2,823 reduced and 402 closed positions. Its largest new stake was South Bow Corp: 18,412,117 shares worth $434M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.82B.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q4 2024 buy was South Bow Corp: 18,412,117 shares worth $434M.
- Royal Bank of Canada added most to NVIDIA in Q4 2024, an estimated $1.53B increase.
- Royal Bank of Canada's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.82B.
- Royal Bank of Canada fully exited CATALENT, INC. in Q4 2024, selling an estimated $43.7M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $501B portfolio in Q4 2024.
- Royal Bank of Canada opened 484 new positions and closed 402 in Q4 2024.
- Royal Bank of Canada's portfolio value rose 2.2% quarter-over-quarter to $501B.
Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.